| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34e0745fe73021e7071124b3eb13d8a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ee68a3716539b3cf9314f89d8c2f216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7d7d69e82f168af141fca6490e66f07 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| filingDate |
2011-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dd8b3ba56430ba8748cc20f287f7c1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c74605663cef7134bf24ae1c7e39af48 |
| publicationDate |
2011-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011145808-A2 |
| titleOfInvention |
Composition for treating chronic hepatitis b, containing clevudine and adefovir dipivoxil |
| abstract |
The present invention relates to a composition for treating chronic hepatitis B, containing clevudine and adefovir dipivoxil. The combined formulation of the present invention maximizes the effect for treating diseases caused by infection of hepatitis B virus and shows a mutual inhibitory activity against a resistant virus compared with a single-component formulation. |
| priorityDate |
2010-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |